Burden and management of viral respiratory infections in the pediatric population: What the COVID-19 pandemic has changed
Viral infections are the largest major cause of respiratory diseases in children. Clinical severity can range from asymptomatic or mild infections to severe or fatal outcomes. Moreover, a wide variety of viral pathogens can cause upper and/or lower respiratory tract infections.
The COVID-19 pandemic has significantly changed the pattern and severity of viral infections as well as the view of healthcare stake holders on viral diseases. In this webinar, the burden and management of viral respiratory tract infections in the pediatric population will be discussed, and the presentation will be illustrated by clinical cases.
Key learning objectives
- Discover the significance of respiratory diseases in children and the contribution of the different viral pathogens
- Understand how the COVID-19 pandemic has changed the occurrence of usual viruses
- Find out how the pandemic has changed the view of healthcare stakeholders (e.g. clinicians, laboratories, pharmaceutical and diagnostics industry, ...) on viral diseases
- Explore the utility and the possible limitations of the multiplex testing approach
Who should attend
Laboratory directors, laboratory managers, clinical researchers, infectious disease specialists, pediatricians, virologists, and public health professionals
Accreditation Statement
SelectScience is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program